Panther Fusion Platform

Awarded Limited / Sole Source Justification Posted

Solicitation number
W81XWH20Q0037
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
W81XWH20P0051 Federal contract award
Place of performance
MA 01752 USA

Notice details come from SAM.gov. Updated .

About this opportunity

The Walter Reed Army Institute of Research published a Limited/Sole Source Justification Notice to acquire a Panther Fusion platform from Gen-Probe, a subsidiary of Hologic, to implement Hologic's pan-coronavirus and SARS-CoV-2 assays on the platform for rapid coronavirus detection. The Notice cited the Panther Fusion's ability to process 225-500 samples in an eight-hour period to address the unusual and compelling urgency under the COVID-19 public health emergency. The contract for the Panther Fusion open access platform technology was awarded non-competitively to Gen-Probe for an undisclosed amount utilizing fiscal year 2020 funds.

Notice text

Diagnostics and Countermeasures Branch (DCB) to acquire the Panther Fusion open access platform for the clinical Panther system currently deployed within DCB and implement Hologic pan-coronavirus (OC43, HKU1, NC63, 229E) and Gen Probe SARS-CoV-2 EUA assays.

The Panther Fusion open access platform is a high-throughput platform technology that can be implemented for rapid coronavirus detection, Hologic pan-coronavirus (OC43, HKU1, NC63, 229E) and Gen Probe SARS-CoV-2 EUA assays.

Awarded contract W81XWH20P0051 to unknown vendor for unknown amount on 2020-03-03.

Files

File Type Posted
WRAIRFusionSSJ_SP_Redacted.pdf PDF

Notice history

Notice Type Posted
This notice Latest Limited / Sole Source Justification
Panther Fusion Latest special notice Special Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity